“Addressing these scale-up considerations in upstream mAb process development ultimately comes down to the timeline, budget, and priority of the developer,” says Leslie Wolfe, site head and ...

One way to address the cost issue is to streamline upstream ... bioprocess development, you must think about the entire workflow and the goal of the modeling.” Process modeling has limited ...

In this webcast, Catalent will share a case study of a monoclonal antibody (mAb) from clinical to ... expanded to include early phase development and tech transfer to GMP. Daniel Pirsch Senior ...

In this GEN webinar, Gerben Zijlstra, PhD, and Jean-Marc Cappia, both experts in process intensification, explore the ...

5 Below is a demonstration of using process Raman as a viable PAT solution for accurate, real-time quantification of mAb concentration ... Figure 2. Upstream and downstream workflow for production ...